Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
Alexandra Fletcher-Jones, Keri L. Hildick, Ashley J. Evans, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity
Evan C. Rosenberg, Simon Chamberland, Michaël Bazelot, et al.
Neuron (2023) Vol. 111, Iss. 8, pp. 1282-1300.e8
Open Access | Times Cited: 53
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 103
Molecular crosstalk between GPCR and receptor tyrosine-protein kinase in neuroblastoma: molecular mechanism and therapeutic implications
Kousik Maparu, Dhrita Chatterjee, Ramandeep Kaur, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Activation of CNR1/PI3K/AKT Pathway by Tanshinone IIA Protects Hippocampal Neurons and Ameliorates Sleep Deprivation-Induced Cognitive Dysfunction in Rats
Ziheng Li, Li Cheng, Chunyi Wen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias
Jamie J. Manning, Hayley M. Green, Michelle Glass, et al.
Neuropharmacology (2021) Vol. 193, pp. 108611-108611
Closed Access | Times Cited: 30
Impact of the mouse estrus cycle on cannabinoid receptor agonist‐induced molecular and behavioral outcomes
Hye Ji J. Kim, Ayat Zagzoog, Tallan Black, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 18
Modeling the Effect of Cannabinoid Exposure During Human Neurodevelopment Using Bidimensional and Tridimensional Cultures
Enrique Estudillo, Jorge Iván Castillo-Arellano, Emilio G. Martínez, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 70-70
Open Access
International Symposium on Ruminant Physiology: The involvement of the endocannabinoid system in metabolic and inflammatory responses in dairy cows during negative energy balance
Maya Zachut, Yana Butenko, Priscila dos Santos Silva
Journal of Dairy Science (2025)
Open Access
Alcohol outcomes on anxiety, impulsivity and spatial memory: Possible Omega-3 amelioration effects
C. Valentin, A Paula, Balaszczuk Verónica, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111281-111281
Closed Access
β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma
Parker Mathews, Xiaobei Wang, Jian Wu, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 496-496
Open Access
A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand-binding assay
Leire Borrega‐Román, Bradley L. Hoare, Miroslav Kosar, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease
Emily E. Oliver, Erin K. Hughes, Meaghan Puckett, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1609-1609
Open Access | Times Cited: 19
Electroacupuncture Reduces Anxiety Associated With Inflammatory Bowel Disease By Acting on Cannabinoid CB1 Receptors in the Ventral Hippocampus in Mice
Xuefei Hu, Hong Zhang, Lingling Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Positive allosteric modulation of the cannabinoid CB1 receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kinetics
Hayley M. Green, Jamie J. Manning, Ian R. Greig, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 19, pp. 3642-3662
Open Access | Times Cited: 2
SGIP1 binding to the α-helical H9 domain of cannabinoid receptor 1 promotes axonal surface expression
Alexandra Fletcher-Jones, Ellen Spackman, Tim J. Craig, et al.
Journal of Cell Science (2024) Vol. 137, Iss. 11
Open Access | Times Cited: 2
Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling
Adrián Bartoll, Ana Toledano‐Zaragoza, Josefina Casas, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 11
Open Access | Times Cited: 17
Noncanonical Activity of Endocannabinoids and Their Receptors in Central and Peripheral Synapses
О. П. Балезина, Е. О. Тарасова, А. Е. Gaydukov
Biochemistry (Moscow) (2021) Vol. 86, Iss. 7, pp. 818-832
Closed Access | Times Cited: 15
Enhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brain
Colin J. Murray, Haley A. Vecchiarelli, Marie‐Ève Tremblay
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 6
SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function
Oleh Durydivka, Ken Mackie, Jaroslav Blahoš
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation
Dongxin Chen, Huirong Tang, Hongchao Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Multiple Sgip1 splice variants inhibit cannabinoid receptor 1 internalization
Oleh Durydivka, Matej Gazdarica, Kateřina Večerková, et al.
Gene (2023) Vol. 892, pp. 147851-147851
Open Access | Times Cited: 5
Coordinated Regulation of CB1 Cannabinoid Receptors and Anandamide Metabolism Stabilizes Network Activity during Homeostatic Downscaling
Michael Ye, Sarah Monroe, Sean M. Gay, et al.
eNeuro (2022) Vol. 9, Iss. 6, pp. ENEURO.0276-22.2022
Open Access | Times Cited: 8
SGIP1 modulates kinetics and interactions of the cannabinoid receptor 1 and G protein‐coupled receptor kinase 3 signalosome
Matej Gazdarica, Judith Noda, Oleh Durydivka, et al.
Journal of Neurochemistry (2021) Vol. 160, Iss. 6, pp. 625-642
Open Access | Times Cited: 10
Loss of Ca V 1.3 RNA editing enhances mouse hippocampal plasticity, learning, and memory
Jing Zhai, Sheeja Navakkode, Sean Qing Zhang Yeow, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 32
Open Access | Times Cited: 7
Linking the G-protein-coupled receptor 55 (GPR55) to the cannabinoid receptors (CB1 and CB2): A new narrative
Paula Morales, Raquel Guerrero‐Alba, Bruno A. Marichal‐Cancino
Elsevier eBooks (2023), pp. 395-406
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top